
Mehmet S Uyanik, MD
@Dr_MSU
Followers
2K
Following
2K
Media
862
Statuses
3K
Stem Cell Transplantation and Cellular Therapies Fellow at Mayo Clinics, FL
Jacksonville, FL
Joined June 2021
🗣:🇱🇷/👥️:👨👩👧👦💭.Dum vivis, sperare debet. (=As long as you live you must hope.)
1
0
11
RT @CanerSaygin: Very excited to share our paper investigating the evolution of therapy-related CH in myeloma pts treated w/ or w/o LEN. Ca….
nature.com
Leukemia - Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma
0
24
0
RT @DrHKantarjian: SQ blinatumomab is highly effective in R-R ALL with CR/CRh rate of 77%, MRD-negativity rate of 91%, and 12-month OS rate….
0
29
0
RT @NitinJainMD: 👉Here is an updated version of the Table which I initially posted post ASH2024. 👉Now Updated with EHA 2025 data including….
0
41
0
RT @NitinJainMD: 👉👉We report case series of 6 patients with T-ALL/LBL who developed rhabdomyolysis after receiving nelarabine .👉 Check CK i….
0
15
0
RT @abouabdrahman0: 🧵 Nivolumab-AVD vs BV-AVD in Older cHL (S1826) 🩺🩻. 1️⃣ Population:.•cHL ≥60y (median 66) advanced stage (III-IV).•99 pa….
0
7
0
🗣:🇹🇷/👥️:👨👩👦🤣.Bence ulaştırma bakanlığı, kara yolları genel müdürlüğü ve trafik şube el ele verip tüm radarlardan önce John Carpenter'dan "The End" (Tabiri diğerle meşhur Nuri Alço Operasyon Müziği) melodisini çaldırsın sürücülere!. https://=hmZS4yMglDMHWh_p…
Türkiye'de ilk 'Melodili Yol' yapıldı. • Sürücüler belirli bir hızda Mozart'ın Türk Marşı bestesini duyabiliyor.
0
0
0
RT @BloodJournal: Cyclophosphamide to ablate CAR T cells is an effective strategy to mitigate steroid-refractory neurotoxicity syndrome neu….
ashpublications.org
Distinct from other chimeric antigen receptor (CAR) therapies, B-cell maturation antigen–targeted CAR T-cell therapy can cause non-immune effector cell–ass
0
25
0
RT @AML_Hub: CONGRESS | #ASCO25 | POSTER.Mehmet Uyanik @Dr_MSU @MDAndersonNews shares efficacy and safety results from a phase II trial (NC….
0
1
0
In vivo CAR T-cell therapy offers advantages such as reduced production time, minimized cytokine release, and a lower risk of secondary malignancies, representing a promising advancement in the field.
Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get this powerful therapy to more people.
0
0
0
Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in patients with COPD.
Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the MATINEE study presented at the American Thoracic Society (ATS) 2025 International
0
0
0
The neoantigens that result from the splicing errors are located inside cancer cells. This required a TCR approach that empowers T cells to peer inside other cells and identify if there are abnormal proteins. “It’s akin to giving T cells X-ray vision,” Dr. Klebanoff says.
In a new study published in @CellPressNews, researchers from MSK and @fredhutch show that it may be possible to develop an #immunotherapy-based approach for #AcuteMyeloidLeukemia and #myelodysplastic syndrome. “This is a potential breakthrough,” says Dr. Omar Abdel-Wahab. “We’re
0
0
1